SCHEMBL7679763

SCHEMBL7679763

NC(=O)CC(C(=O)O)N1Cc2c(N)cccc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 3/20 0.42
STAT3 P40763 1/20 0.38
TNF P01375 5/20 0.37
BRD4 O60885 1/20 0.37
IL1B P01584 1/20 0.37
IKZF1 Q13422 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
IKZF3 Q9UKT9 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
XIAP P98170 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SDCBP O00560 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677588 0.91 ALOX15 (0.46) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL30001202 0.88 ALOX15 (0.46) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL502389 0.88 ALOX15 (0.46) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL20766604 0.87 ALOX15 (0.45) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL20766605 0.87 ALOX15 (0.45) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7680330 0.86 MAPT (0.44) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7679480 0.85 ALOX15 (0.43) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL2169082 0.85 ALDH1A1 (0.40) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7671077 0.84 ALOX15 (0.43) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL14506392 0.84 KDM4E (0.52) ALOX15MAPTSMN1; SMN2KDM4ESTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed